Regulatory T cell epitopes
The present is directed to compositions comprising regulatory T cell epitopes, wherein said epitopes comprise a polypeptide comprising at least a portion of SEQ NOS: 1-14, fragments and/or variants thereof, as well as methods of producing and using the same.
1. A method of inducing regulatory T-cells to suppress immune response in a subject comprising administrating to the subject a therapeutically effective amount of a T-cell epitope composition, wherein the T-cell epitope composition comprises one or more isolated T-cell epitope polypeptides, wherein at least one isolated T-cell epitope polypeptide consists of the amino acid sequence of SEQ ID NO: 1.
2. The method of claim 1 , wherein the T-cell epitope composition further comprises at least one isolated T-cell epitope polypeptide consisting of an amino acid sequence selected from the group consisting of SEQ ID NOS: 2-14.
3. The method of claim 1 , wherein the T-cell epitope composition further comprises an effective amount of one or more antigens and/or allergens.
4. The method of claim 1 , wherein the immune suppressive effect is mediated by natural regulatory T cells.
5. The method of claim 1 , wherein the immune suppressive effect is mediated by adaptive regulatory T-cells.
6. The method of claim 1 , wherein the T-cell epitope composition suppresses an effector T-cell response.
7. The method of claim 6 , wherein the T-cell epitope composition suppresses a cytokine secretion of effector T-cells.
8. The method of claim 1 , wherein the T-cell epitope composition suppresses a helper T-cell response.
9. The method of claim 1 , wherein the T-cell epitope composition suppresses a B-cell response.